165 related articles for article (PubMed ID: 30304550)
1. Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer.
Li W; Lu Y; Yu X; Yong M; Ma D; Gao Q
J Cell Biochem; 2019 Apr; 120(4):6361-6369. PubMed ID: 30304550
[TBL] [Abstract][Full Text] [Related]
2. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
[TBL] [Abstract][Full Text] [Related]
3. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.
Pinet S; Bessette B; Vedrenne N; Lacroix A; Richard L; Jauberteau MO; Battu S; Lalloué F
Oncotarget; 2016 Aug; 7(31):50349-50364. PubMed ID: 27385098
[TBL] [Abstract][Full Text] [Related]
4. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
[TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
[TBL] [Abstract][Full Text] [Related]
7. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
[TBL] [Abstract][Full Text] [Related]
8. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
[TBL] [Abstract][Full Text] [Related]
9. Exosome-derived miRNAs and ovarian carcinoma progression.
Vaksman O; Tropé C; Davidson B; Reich R
Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
[TBL] [Abstract][Full Text] [Related]
10. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
Zhang W; Ou X; Wu X
Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis.
He L; Zhu W; Chen Q; Yuan Y; Wang Y; Wang J; Wu X
Theranostics; 2019; 9(26):8206-8220. PubMed ID: 31754391
[No Abstract] [Full Text] [Related]
12. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
Hang W; Feng Y; Sang Z; Yang Y; Zhu Y; Huang Q; Xi X
Int J Mol Med; 2019 Jan; 43(1):256-266. PubMed ID: 30365097
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of tyrosine kinase receptor B promotes metastasis of ovarian serous adenocarcinoma by lymphangiogenesis.
Zheng W; Dai Q; Tao P; Sun A; Wang Y; Bao L; Zhang G
Tumori; 2011; 97(6):756-61. PubMed ID: 22322843
[TBL] [Abstract][Full Text] [Related]
16. Characterization and proteomic analysis of ovarian cancer-derived exosomes.
Liang B; Peng P; Chen S; Li L; Zhang M; Cao D; Yang J; Li H; Gui T; Li X; Shen K
J Proteomics; 2013 Mar; 80():171-82. PubMed ID: 23333927
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients.
Tang S; Zheng K; Tang Y; Li Z; Zou T; Liu D
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180050
[TBL] [Abstract][Full Text] [Related]
18. Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.
Kharmate G; Hosseini-Beheshti E; Caradec J; Chin MY; Tomlinson Guns ES
PLoS One; 2016; 11(5):e0154967. PubMed ID: 27152724
[TBL] [Abstract][Full Text] [Related]
19. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
20. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals.
Zlotogorski-Hurvitz A; Dayan D; Chaushu G; Salo T; Vered M
J Cancer Res Clin Oncol; 2016 Jan; 142(1):101-10. PubMed ID: 26115960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
